BR9813637A - Compostos e métodos para a detecção e prevençãode infecção por t. cruzi - Google Patents

Compostos e métodos para a detecção e prevençãode infecção por t. cruzi

Info

Publication number
BR9813637A
BR9813637A BR9813637-2A BR9813637A BR9813637A BR 9813637 A BR9813637 A BR 9813637A BR 9813637 A BR9813637 A BR 9813637A BR 9813637 A BR9813637 A BR 9813637A
Authority
BR
Brazil
Prior art keywords
compounds
infection
cruzi
prevention
detection
Prior art date
Application number
BR9813637-2A
Other languages
English (en)
Inventor
Steven G Reed
A Yasir
W Skeiky
Michael J Lodes
Raymondl Houghton
John M Smith
Patricia D Mcneill
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9813637A publication Critical patent/BR9813637A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"COMPOSTOS E MéTODOS PARA A DETECçãO EPREVENçãO DE INFECçãO POR T. CRUZI". Compostos eprocessos são providos para diagnóstico de infecção comTrypanosoma cruzi. Os compostos mostrados são polipeptídios, ouanticorpos para os mesmos, que contêm um ou mais epítopos deantígenos de T. cruzi. Os compostos são úteis em uma variedadede ensaios imuno para detecção de infecção de T. cruzi. Oscompostos polipeptídios ainda são úteis em vacinas ecomposições farmacêuticas para indução de imunidade protetoracontra doença de Chagas em indivíduos expostos a T. cruzi.
BR9813637-2A 1997-12-18 1998-12-04 Compostos e métodos para a detecção e prevençãode infecção por t. cruzi BR9813637A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/993,674 US6228372B1 (en) 1997-04-15 1997-12-18 Compounds and methods for the detection and prevention of T. cruzi infection
PCT/US1998/025871 WO1999031246A1 (en) 1997-12-18 1998-12-04 Compounds and methods for the detection and prevention of t. cruzi infection

Publications (1)

Publication Number Publication Date
BR9813637A true BR9813637A (pt) 2001-12-04

Family

ID=25539818

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813637-2A BR9813637A (pt) 1997-12-18 1998-12-04 Compostos e métodos para a detecção e prevençãode infecção por t. cruzi

Country Status (8)

Country Link
US (1) US6228372B1 (pt)
EP (1) EP1038000A1 (pt)
JP (1) JP2002508506A (pt)
AR (1) AR014132A1 (pt)
AU (1) AU1805799A (pt)
BR (1) BR9813637A (pt)
CO (1) CO4820439A1 (pt)
WO (1) WO1999031246A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6419933B1 (en) 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
EP1945248A4 (en) * 2005-11-03 2008-12-31 Inbios Internat Inc COMPOSITIONS AND METHODS FOR DETECTING A TRYPANOSOMA CRUZI INFECTION
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
CA3023887A1 (en) * 2007-12-27 2009-07-09 Abbott Laboratories Anti-t. cruzi antibodies and methods of use
US8231881B2 (en) 2008-07-03 2012-07-31 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
EP3215849B1 (en) * 2014-11-06 2018-12-19 Roche Diagnostics GmbH Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (pt) 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US5916572A (en) 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection

Also Published As

Publication number Publication date
WO1999031246A1 (en) 1999-06-24
CO4820439A1 (es) 1999-07-28
AU1805799A (en) 1999-07-05
US6228372B1 (en) 2001-05-08
EP1038000A1 (en) 2000-09-27
JP2002508506A (ja) 2002-03-19
AR014132A1 (es) 2001-02-07

Similar Documents

Publication Publication Date Title
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
NO975598D0 (no) Monoklonale ape-antistoffer som er spesifikke for primatiserte humane B7.1- og/eller B7.2-former, samt farmasöytiske sammensetninger
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
DE59010787D1 (de) Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper
PT824699E (pt) Compostos e metodos para o diagnostico da leishmaniose
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
PT851927E (pt) Compostos para imunoterapia e diagnostico de tuberculose
BR9611455A (pt) Compostos e métodos para a detecção e prevenção de infecção por t. cruzi.
BRPI0413495A (pt) reagentes de peptìdeos especìficos para prìons e seus usos
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
AU3245000A (en) Compounds and methods for the detection and prevention of (t. cruzi) infection
BR9813637A (pt) Compostos e métodos para a detecção e prevençãode infecção por t. cruzi
BR0113213A (pt) Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
DE68921150D1 (de) Wirkung von hormonen.
DK0882132T3 (da) Et kombineret humant cytomegalovirus-antigen og anvendelse heraf
BR9903250A (pt) Antìgenos e imunoanálises para diagnóstico da doença de chagas.
FI900272A0 (fi) Ventilkonstruktion foer en saeck eller motsvarande som skall fyllas med luft.
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
NO179212C (no) Kondensasjonsprodukter egnet som demulgatorer for olje-i-vann-emulsjoner, samt anvendelse av produktene
SE9002671D0 (sv) Nya peptider, diagnostiska antigener, anvaendning daerav och vacciner
AR012896A1 (es) Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.